Nelotanserin Completed Phase 2 Trials for Dementia With Lewy Body Disease / Parkinsons Disease With Dementia (PDD) / Rapid Eye Movement Sleep Behavior Disorder Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02708186Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)